Private Meetings Review Grants for Hearing Research Innovations
Published Date: 3/17/2025
Notice
Summary
The National Institute on Deafness and Other Communication Disorders is holding two private virtual meetings in early April 2025 to review grant applications from small businesses. These closed sessions protect sensitive info like trade secrets and personal details. This process helps decide who gets funding to support research on hearing and communication disorders.
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Virtual grant review meetings set
If you run a small business that applied for NIDCD funding, the NIH will hold virtual meetings to review your grant applications on April 2, 2025 (12:00 p.m. to 5:00 p.m.) and April 4, 2025 (12:00 p.m. to 3:00 p.m.). These sessions will evaluate applications for the NIDCD Hearing and Balance Small Business review and the NIDCD VSL Small Business grant program and help decide who receives research funding.
Applicant confidentiality protected
The meetings will be closed to the public under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to protect confidential trade secrets, patentable material, and personal information in grant applications. If you submitted an application, sensitive business and personal details in your submission will be kept private during the review.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-20771, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding several closed virtual meetings in early November 2026 to review and evaluate grant applications. These meetings protect private info and trade secrets, affecting researchers seeking funding. No direct money changes are announced, but these reviews decide who gets research grants.
2026-20705, Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Antibody Specifically Binding to Severe Fever With Thrombocytopenia Syndrome Virus Antigen and Use Thereof
The National Institute of Allergy and Infectious Diseases plans to give Korea National Institute of Health an exclusive license to develop and sell a special antibody that targets a dangerous virus causing severe fever and low platelets. This deal helps speed up turning the invention into real-world treatments. Comments or license requests must be sent by October 26, 2026.
2026-20424, National Cancer Institute; Notice of Meeting
The President's Cancer Panel is holding a free virtual meeting on October 15, 2026, to talk about how GLP-1 medications can help lower cancer risks linked to obesity. Anyone interested can join online or send in comments beforehand. This meeting is a great chance for patients, doctors, and researchers to learn about new ways to fight cancer and improve health.
2026-20365, Center For Scientific Review; Notice of Closed Meetings
The NIH's Center for Scientific Review is holding several closed virtual meetings on October 29-30, 2026, to review and evaluate grant applications. These meetings protect private info and trade secrets while deciding which research projects get funding. Scientists applying for grants in areas like biochemistry, software engineering, and mental health will be affected, with no direct money changes announced but important decisions coming soon.
2026-20151, Notice of NIH Tribal Consultations and Listening Session
The NIH is inviting Tribal leaders and members to join two important meetings and a listening session during the National Congress of American Indians Annual Convention in October 2026. They’ll talk about new health research projects, renewing support for Tribal health centers, and shaping a new Tribal Data Sovereignty Policy. Tribes can also send their thoughts by November 20, 2026, helping shape future health programs and policies.
2026-19719, Center for Scientific Review; Amended Notice of Meeting
The NIH’s Center for Scientific Review is shortening a key meeting from two days to just one day on October 13, 2026, keeping the same 9 a.m. to 6 p.m. hours. This change affects members of the Surgical Sciences and Bioengineering review group and means less time in the room but no public access. No money changes or delays are expected—just a quicker, tighter meeting!
Previous / Next Documents
Previous: 2025-04285, Importer of Controlled Substance Application: Fisher Clinical Services, Inc.
Fisher Clinical Services, Inc. wants to become an official importer of some controlled substances, including marijuana extracts and other drugs. People and companies involved with these substances can share their thoughts or ask for a hearing by April 16, 2025. This move could impact how these drugs are imported and regulated, so keep an eye on the deadline to have your say!
Next: 2025-04287, Monosodium Glutamate From the People's Republic of China: Preliminary Affirmative Determination of Circumvention; Correction
The U.S. Department of Commerce fixed some mistakes in the paperwork for a recent decision about imports of monosodium glutamate (MSG) from China. This update affects importers and exporters who must now use the corrected forms to follow new rules about extra duties. These changes help make sure the right taxes are paid on MSG imports starting from the original February 21, 2025 notice.